NF-kappaBの阻害と腫瘍性Rasは,侵襲的なヒトの表皮性腫瘍を誘発する
Maya Dajee1, Mirella Lazarov, Jennifer Y Zhang
1Veterans Affairs Palo Alto Healthcare System and the Program in Epithelial Biology, Stanford University School of Medicine, Stanford, California 94305, USA.
Nature
|February 7, 2003
まとめ
核因子カッパB (NF-kappaB) と腫瘍性Rasは,通常,ヒトの表皮細胞の細胞サイクルを停止する. 腫瘍性RasでNF-kappaBを阻害すると,状細胞癌を引き起こす可能性があります.
科学分野:
- 腫瘍学 腫瘍学
- 細胞生物学 細胞生物学
- 皮膚科 皮膚科について
背景:
- 核因子NF-kappaBと腫瘍性Rasは,ヒトがんの一般的な部位である表皮の細胞増殖を調節する.
- ネズミの状細胞癌に関与しているが,ヒトの表皮細胞における正確な役割は不明である.
- RasとNF-kappaB経路を標的とする治療法は,ヒトのがん治療のために開発中です.
研究 の 目的:
- ヒトの正常な表皮細胞におけるNF-kappaBと腫瘍性Rasの機能を変化させる効果を調査する.
- これらの要因が細胞サイクル停止と腫瘍発生に影響を与えるメカニズムを決定する.
- Ras誘発の悪性変異を促進するNF-kappaB阻害の可能性を評価する.
主な方法:
- ヒトの正常な表皮細胞を用いた.
- 細胞サイクル停止に対するNF-kappaBと腫瘍性Rasの影響を調査した.
- Ras誘発の成長停止を調節するIkappaBalphaの役割を調べました.
- ヒト細胞腫瘍形成のラミニン5とアルファ6ベータ4インテグリンへの依存度を評価した.
主要な成果:
- NF-kappaBと腫瘍性Rasの両方が,正常なヒトの表皮細胞の細胞サイクル停止を誘発することが判明しました.
- 腫瘍性Ras誘発の成長停止は,IkappaBalpha媒介のNF-kappaB阻害によって克服される可能性がある.
- この封鎖は,腫瘍性Rasと組み合わせて,状細胞がんに似た悪性ヒトの表皮組織を生成しました.
- この文脈におけるヒト細胞腫瘍形成は,ラミニン5とアルファ6ベータ4インテグリンに依存していた.
結論:
- NF-kappaBと腫瘍性Rasは,ヒトの表皮における細胞サイクル制御の重要な調節体として作用する.
- イカッパバルファは,腫瘍性Ras. oncogenicからの成長阻害信号を回避することができます.
- RasとNF-kappaB阻害の併用作用は,ヒトの侵襲性腫瘍を誘発し,潜在的な治療的脆弱性を強調する可能性があります.
関連する概念動画
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...


